-
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.
Immunochemistry. 1978 Jul;15(7):429-36
PMID: 30693
-
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis.
Int J Cancer. 1993 Apr 1;53(6):994-1001
PMID: 8097188
-
Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.
Jpn J Cancer Res. 1994 Feb;85(2):172-8
PMID: 7908285
-
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Nature. 1991 Nov 21;354(6350):233-5
PMID: 1683685
-
Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.
Proc Natl Acad Sci U S A. 1984 Nov;81(22):7161-5
PMID: 6438633
-
Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR.
Mol Immunol. 1990 Aug;27(8):809-17
PMID: 2119481
-
Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.
Proc Natl Acad Sci U S A. 1987 Jan;84(1):214-8
PMID: 3025856
-
Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transfer.
Eur J Immunol. 1992 Sep;22(9):2255-60
PMID: 1355429
-
Technetium-99m-labeled anti-fibrin monoclonal antibody accumulation in an inflammatory focus.
J Nucl Med. 1992 Jun;33(6):1181-2
PMID: 1597735
-
Reduction-mediated technetium-99m labeling of monoclonal antibodies.
J Nucl Med. 1990 May;31(5):692-7
PMID: 2341907
-
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.
Transplantation. 1993 Apr;55(4):766-72; discussion 772-3
PMID: 8097341
-
Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588-92
PMID: 6966400
-
Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
Int J Cancer. 1991 Feb 20;47(4):527-32
PMID: 1671670
-
Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.
J Immunol. 1991 May 15;146(10):3682-6
PMID: 1673988
-
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
Cancer Res. 1990 Feb 15;50(4):1271-8
PMID: 1967552
-
Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer.
Cancer Immunol Immunother. 1993;36(4):267-73
PMID: 8382560
-
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).
J Immunol. 1986 Jul 1;137(1):245-54
PMID: 3086451
-
Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes.
J Nucl Med. 1991 Dec;32(12 ):2209-14
PMID: 1744705
-
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Cancer Res. 1994 Apr 1;54(7):1753-9
PMID: 8137290
-
Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.
Clin Exp Immunol. 1991 Jul;85(1):3-8
PMID: 1712683
-
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.
J Immunol. 1986 Aug 15;137(4):1270-4
PMID: 3525675
-
Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.
Blood. 1990 Aug 15;76(4):783-90
PMID: 1974471
-
Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer.
J Clin Oncol. 1990 Jun;8(6):1083-92
PMID: 2161448
-
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
Biochem J. 1963 Oct;89:114-23
PMID: 14097352
-
Detection of cardiac rejection in mice by radioimmune scintigraphy using 123iodine-labeled anti-ICAM-1 monoclonal antibody.
Acta Cardiol. 1993;48(3):235-43
PMID: 8101409
-
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.
Proc Natl Acad Sci U S A. 1987 May;84(10):3439-43
PMID: 3106970
-
Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.
Cell. 1991 Jun 14;65(6):961-71
PMID: 1675157
-
Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies.
J Immunol. 1981 Apr;126(4):1608-13
PMID: 6970781
-
Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.
Arthritis Rheum. 1994 Jul;37(7):992-9
PMID: 7912930
-
Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Cancer Res. 1992 Jan 15;52(2):377-84
PMID: 1728409
-
Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
Lab Invest. 1994 Nov;71(5):710-8
PMID: 7526040
-
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.
Cancer Res. 1991 Oct 15;51(20):5461-6
PMID: 1913665
-
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody.
J Nucl Med. 1991 Jun;32(6):1162-8
PMID: 2045929
-
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
J Immunol. 1986 Sep 15;137(6):1893-6
PMID: 3091693